What is Hypoplastic Left Heart Syndrome?
Hypoplastic Left Heart Syndrome (HLHS) is a congenital heart condition in which the structures on the left side of the heart—such as the left ventricle, mitral valve, aortic valve, and aorta—are severely underdeveloped. This affects the heart’s ability to pump oxygenated blood to the body, making it a life-threatening condition if not treated shortly after birth.
How HLHS Affects the Heart:
- The left ventricle is too small to pump blood efficiently.
- The mitral and aortic valves are narrowed or absent, restricting blood flow.
- The aorta is smaller than normal, limiting oxygen delivery to the body.
- Blood must bypass the underdeveloped left side, relying on fetal circulation pathways.
Causes and Risk Factors
HLHS occurs due to abnormal heart development during fetal growth. While the exact cause is unknown, several factors may increase the risk:
1. Genetic Factors
- Mutations in specific genes involved in heart development.
- Family history of congenital heart defects.
- HLHS may be linked to certain chromosomal disorders (e.g., Turner Syndrome).
2. Maternal Health & Environmental Factors
- Maternal diabetes or obesity.
- Smoking, drug, or alcohol use during pregnancy.
- Viral infections (e.g., rubella) during early pregnancy.
- Exposure to certain medications or toxins that affect fetal development.
Symptoms of Hypoplastic Left Heart Syndrome
HLHS symptoms usually appear within the first 24-48 hours after birth, as the ductus arteriosus (a temporary fetal blood vessel) closes, restricting blood flow.
Common Symptoms:
- Severe cyanosis (bluish skin, lips, or nails) due to low oxygen levels.
- Difficulty breathing (respiratory distress).
- Weak or absent pulse.
- Poor feeding and lethargy.
- Cold, clammy skin due to inadequate circulation.
Note: HLHS is a medical emergency, and newborns require immediate intervention for survival.
Diagnosis of HLHS
HLHS is often detected before birth using fetal echocardiography (ultrasound of the heart). If not diagnosed prenatally, symptoms after birth prompt urgent evaluation.
Diagnostic Tests:
- Fetal Echocardiogram: Identifies heart defects before birth.
- Pulse Oximetry Screening: Measures oxygen levels in newborns.
- Echocardiogram: Confirms structural abnormalities after birth.
- Chest X-ray: Shows an enlarged heart and fluid buildup.
- Electrocardiogram (ECG): Detects abnormal heart rhythms.
Treatment and Management of HLHS
HLHS requires immediate stabilization and staged surgical interventions to improve heart function.
1. Initial Stabilization
- Prostaglandin infusion: Keeps the ductus arteriosus open to maintain blood flow.
- Oxygen or ventilator support: Assists breathing if needed.
- Intravenous fluids and medications: Prevents dehydration and shock.
2. Staged Surgeries for HLHS
Since HLHS is not curable, a series of three heart surgeries are performed to reroute blood flow.
Stage 1: Norwood Procedure (First Weeks of Life)
- Reconstructs the aorta and right ventricle, allowing blood to reach the body.
- Creates a shunt or conduit for pulmonary circulation.
Stage 2: Glenn Procedure (3-6 Months Old)
- Connects the superior vena cava directly to the pulmonary arteries.
- Reduces heart workload by eliminating the first shunt.
Stage 3: Fontan Procedure (2-4 Years Old)
- Directs all venous blood to the lungs, bypassing the heart.
- Finalizes the single-ventricle circulation.
3. Heart Transplantation
If surgical treatments fail or complications arise, heart transplantation may be required.
4. Lifelong Management
Children with HLHS need long-term cardiac monitoring, medications, and lifestyle adjustments.
Living with HLHS
After treatment, children with HLHS require regular check-ups and cardiac care.
Challenges:
- Increased risk of arrhythmias and heart failure.
- Lower exercise tolerance.
- Possible developmental delays.
Recommended Care:
- Routine echocardiograms & ECGs.
- Low-sodium diet and hydration.
- Monitoring for complications (e.g., clotting or infections).
Resources for More Information